Advertisement

Topics

AIMT To Face FDA Panel In Sep., FDA Lifts Hold On ADVM Trial, OTLK Jumps

02:19 EDT 17 May 2019 | RTTNews

Today's Daily Dose brings you news about Aimmune Therapeutics' upcoming regulatory catalyst; FDA lifting the clinical hold on OPTIC trial; Analyst rating on Outlook Therapeutics and Cellectar Biosciences' $10 million financing.

Original Article: AIMT To Face FDA Panel In Sep., FDA Lifts Hold On ADVM Trial, OTLK Jumps

NEXT ARTICLE

More From BioPortfolio on "AIMT To Face FDA Panel In Sep., FDA Lifts Hold On ADVM Trial, OTLK Jumps"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...